180 related articles for article (PubMed ID: 23592225)
1. Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.
Han Y; Tu WW; Wen YG; Li DP; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Med Oncol; 2013; 30(2):564. PubMed ID: 23592225
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.
Hu H; Chen Y; Cheng S; Li G; Zhang Z
Wien Klin Wochenschr; 2017 Jun; 129(11-12):391-397. PubMed ID: 27830363
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
4. HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.
Zhao XF; Yang YS; Park YK
Int J Clin Oncol; 2020 Dec; 25(12):2044-2054. PubMed ID: 32816159
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype.
Lim JY; Yoon SO; Seol SY; Hong SW; Kim JW; Choi SH; Lee JS; Cho JY
World J Gastroenterol; 2013 Nov; 19(41):7078-88. PubMed ID: 24222951
[TBL] [Abstract][Full Text] [Related]
6. Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer.
Zhou WH; Tang F; Xu J; Wu X; Feng ZY; Li HG; Lin DJ; Shao CK; Liu Q
BMC Cancer; 2011 Sep; 11():397. PubMed ID: 21933426
[TBL] [Abstract][Full Text] [Related]
7. Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer.
Wang Y; He B; Dong Y; He GJ; Qi XW; Li Y; Yang YF; Rao Y; Cen ZS; Han F; Ding J; Li JJ
Cancer Biomark; 2021; 31(3):239-254. PubMed ID: 33896818
[TBL] [Abstract][Full Text] [Related]
8. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
Wang SS; Wuputra K; Liu CJ; Lin YC; Chen YT; Chai CY; Lin CS; Kuo KK; Tsai MH; Wang SW; Chen KK; Miyoshi H; Nakamura Y; Saito S; Hanafusa T; Wu DC; Lin CS; Yokoyama KK
Oncotarget; 2016 Jun; 7(24):36049-36064. PubMed ID: 27144338
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
[TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma.
Pan TT; Jia WD; Yao QY; Sun QK; Ren WH; Huang M; Ma J; Li JS; Ma JL; Yu JH; Ge YS; Liu WB; Zhang CH; Xu GL
Tohoku J Exp Med; 2014 Nov; 234(3):209-19. PubMed ID: 25341685
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
14. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
16. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
17. HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression.
Chang S; Liu J; Guo S; He S; Qiu G; Lu J; Wang J; Fan L; Zhao W; Che X
Oncol Rep; 2016 Jun; 35(6):3577-85. PubMed ID: 27108607
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of serum response factor is correlated with poor prognosis in patients with gastric cancer.
Yin J; Lv X; Hu S; Zhao X; Liu Q; Xie H
Hum Pathol; 2019 Mar; 85():10-17. PubMed ID: 30500416
[TBL] [Abstract][Full Text] [Related]
20. HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma.
Dong Y; Cai Y; Liu B; Jiao X; Li ZT; Guo DY; Li XW; Wang YJ; Yang DK
Future Oncol; 2017 Jul; 13(17):1505-1516. PubMed ID: 28766961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
